Cargando…
Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287236/ https://www.ncbi.nlm.nih.gov/pubmed/35661333 http://dx.doi.org/10.1007/s40262-022-01146-x |
_version_ | 1784748207944761344 |
---|---|
author | Wenzler, Eric Butler, David Tan, Xing Katsube, Takayuki Wajima, Toshihiro |
author_facet | Wenzler, Eric Butler, David Tan, Xing Katsube, Takayuki Wajima, Toshihiro |
author_sort | Wenzler, Eric |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9287236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-92872362022-07-17 Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy Wenzler, Eric Butler, David Tan, Xing Katsube, Takayuki Wajima, Toshihiro Clin Pharmacokinet Correction Springer International Publishing 2022-06-06 2022 /pmc/articles/PMC9287236/ /pubmed/35661333 http://dx.doi.org/10.1007/s40262-022-01146-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Correction Wenzler, Eric Butler, David Tan, Xing Katsube, Takayuki Wajima, Toshihiro Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy |
title | Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy |
title_full | Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy |
title_fullStr | Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy |
title_full_unstemmed | Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy |
title_short | Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy |
title_sort | correction to: pharmacokinetics, pharmacodynamics, and dose optimization of cefiderocol during continuous renal replacement therapy |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287236/ https://www.ncbi.nlm.nih.gov/pubmed/35661333 http://dx.doi.org/10.1007/s40262-022-01146-x |
work_keys_str_mv | AT wenzlereric correctiontopharmacokineticspharmacodynamicsanddoseoptimizationofcefiderocolduringcontinuousrenalreplacementtherapy AT butlerdavid correctiontopharmacokineticspharmacodynamicsanddoseoptimizationofcefiderocolduringcontinuousrenalreplacementtherapy AT tanxing correctiontopharmacokineticspharmacodynamicsanddoseoptimizationofcefiderocolduringcontinuousrenalreplacementtherapy AT katsubetakayuki correctiontopharmacokineticspharmacodynamicsanddoseoptimizationofcefiderocolduringcontinuousrenalreplacementtherapy AT wajimatoshihiro correctiontopharmacokineticspharmacodynamicsanddoseoptimizationofcefiderocolduringcontinuousrenalreplacementtherapy |